Charlottesville, VA, United States of America

Michael Oliver Thorner

USPTO Granted Patents = 14 

Average Co-Inventor Count = 1.7

ph-index = 6

Forward Citations = 93(Granted Patents)


Location History:

  • North Garden, VA (US) (1996 - 2006)
  • Charlottesville, VA (US) (1988 - 2022)

Company Filing History:


Years Active: 1988-2022

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Michael Oliver Thorner: Innovator in Growth Hormone Research

Introduction

Michael Oliver Thorner is a prominent inventor based in Charlottesville, VA (US). He has made significant contributions to the field of medicine, particularly in the area of growth hormone deficiency. With a total of 14 patents to his name, Thorner's work has had a substantial impact on the understanding and treatment of this condition.

Latest Patents

Among his latest patents is a groundbreaking method for detecting and treating growth hormone deficiency (GHD). This innovative approach utilizes MK-0677, a new oral method that aids in the detection of GHD. Additionally, it describes a method for treating GHD in children who possess a functional hypothalamic-pituitary GH axis. This dual focus on detection and treatment showcases Thorner's commitment to advancing medical science.

Career Highlights

Thorner has had a distinguished career, working with notable institutions such as the University of Virginia and American Cyanamid Company. His experience in these organizations has allowed him to collaborate with other experts in the field and further his research endeavors.

Collaborations

Some of Thorner's notable coworkers include Bruce D. Gaylinn and John R. Zysk. Their collaborative efforts have contributed to the success of his research and the development of his patents.

Conclusion

Michael Oliver Thorner's innovative work in the field of growth hormone research has led to significant advancements in the detection and treatment of growth hormone deficiency. His contributions continue to influence the medical community and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…